Global Irritable Bowel Syndrome Treatment Market By Drug Type Forecast (2015-2023)
Linaclotide segment accounted for the largest market share in the irritable bowel syndrome treatment market, and is expected to reach usd 958.50 million in 2023 from usd 598.10 million in 2017.This market is projected to grow at a cagr of 7.95% dur